Danaher Corporation (dhr)
DHR Financials
| Trailing P/E | 35.65 |
| Forward P/E | 21.51 |
| Price/Sales | 5.60 |
| Price/Book | 2.67 |
| Market cap | $140.58B |
| Avg volume | 5224137.0 |
| Shares outstanding | 702986054.0 |
Danaher Corporation FAQ
What does Danaher Corporation (DHR) do?
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology s…
What is DHR's P/E ratio?
Danaher Corporation has a trailing P/E of 35.65× based on publicly available market data.
Does DHR pay a dividend?
Indicated dividend yield: 0.8%. Confirm ex-dates and payout history in Vest Terminal.
What sector is DHR in?
Danaher Corporation is classified in Healthcare (Diagnostics & Research) on NYQ.
What is DHR's market capitalization?
Approximate market cap: $140.58B.
What are the main risks for DHR?
Key risks include elevated valuation, among factors on this page.
What are the strengths of DHR?
Potential positives include revenue growth of 5.5% year-over-year, earnings growth of 59.7% year-over-year.
Where can I get analyst estimates for DHR?
Consensus estimates, price targets, and detailed analyst data for Danaher Corporation are available to Professional subscribers in Vest Terminal — not on this public summary page.